Evogene Ltd
Research Evogene Ltd (EVGN) on Bullrun: market cap USD 5.73M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEVGN
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.73M
- Financial periodQ1 2026
- RevenueUSD 334.00K
- Net income-USD 5.87M
- Free cash flow-USD 2.96M
- Gross margin61.1%
Valuation Snapshot
latest market cap is USD 5.73M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.95M | -USD 8.48M | -USD 13.64M | -6.0% | -1.17 | USD 12.96M | USD 2.20M | -USD 82.00K |
| FY2024 | USD 8.15M | -USD 16.49M | -USD 20.97M | 70.0% | -3.07 | USD 15.30M | USD 12.87M | -USD 1.45M |
| FY2023 | USD 5.64M | -USD 23.88M | n/a | 70.0% | -19.06 | USD 20.77M | USD 11.51M | USD 12.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.73M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.59M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 12.18M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 42.46M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 28.85M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 67.52M | n/a | n/a | n/a |
About Evogene Ltd
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Evogene Ltd's market cap?
Evogene Ltd's market capitalization is USD 5.73M.
What does Evogene Ltd do?
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses.